Adverum Biotechnologies is a clinical-stage company dedicated to pioneering gene therapy for prevalent ocular diseases, aiming to provide functional cures that restore vision and prevent blindness. Utilizing its proprietary intravitreal platform, Adverum is developing innovative, single-administration treatments to replace the need for frequent ocular injections, transforming the standard of care and addressing significant unmet medical needs in eye health.
